vs

Side-by-side financial comparison of CHEMED CORP (CHE) and Stride, Inc. (LRN). Click either name above to swap in a different company.

Stride, Inc. is the larger business by last-quarter revenue ($629.9M vs $420.0M, roughly 1.5× CHEMED CORP). CHEMED CORP runs the higher net margin — 15.8% vs 14.1%, a 1.7% gap on every dollar of revenue. On growth, CHEMED CORP posted the faster year-over-year revenue change (3.1% vs 2.7%). Over the past eight quarters, Stride, Inc.'s revenue compounded faster (6.9% CAGR vs 5.9%).

LG Chem Ltd., often referred to as LG Chemical, is the largest Korean chemical company and is headquartered in Seoul, South Korea. It was the 9th largest chemical company in the world by sales in 2021. It was first established as the Lucky Chemical Industrial Corporation, which manufactured cosmetics. It is now solely a business-to-business company.

Stride, Inc. is a for-profit education company that provides online and blended education programs. Stride, Inc. is an education management organization (EMO) that provides online education designed as an alternative to traditional "brick and mortar" education for public school students from kindergarten to 12th grade, as well as career learning programs. As of 2012, publicly traded Stride, Inc. was the largest EMO in terms of enrollment.

CHE vs LRN — Head-to-Head

Bigger by revenue
LRN
LRN
1.5× larger
LRN
$629.9M
$420.0M
CHE
Growing faster (revenue YoY)
CHE
CHE
+0.4% gap
CHE
3.1%
2.7%
LRN
Higher net margin
CHE
CHE
1.7% more per $
CHE
15.8%
14.1%
LRN
Faster 2-yr revenue CAGR
LRN
LRN
Annualised
LRN
6.9%
5.9%
CHE

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CHE
CHE
LRN
LRN
Revenue
$420.0M
$629.9M
Net Profit
$66.3M
$88.5M
Gross Margin
Operating Margin
20.1%
20.5%
Net Margin
15.8%
14.1%
Revenue YoY
3.1%
2.7%
Net Profit YoY
8.5%
EPS (diluted)
$1.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHE
CHE
LRN
LRN
Q3 26
$629.9M
Q1 26
$420.0M
Q4 25
$639.3M
$631.3M
Q3 25
$624.9M
$620.9M
Q2 25
$618.8M
$653.6M
Q1 25
$646.9M
$613.4M
Q4 24
$411.0M
$587.2M
Q3 24
$391.4M
$551.1M
Net Profit
CHE
CHE
LRN
LRN
Q3 26
$88.5M
Q1 26
$66.3M
Q4 25
$76.8M
$99.5M
Q3 25
$64.2M
$68.8M
Q2 25
$52.5M
$51.3M
Q1 25
$71.8M
$99.3M
Q4 24
$90.3M
$96.4M
Q3 24
$75.8M
$40.9M
Gross Margin
CHE
CHE
LRN
LRN
Q3 26
Q1 26
Q4 25
35.2%
41.1%
Q3 25
31.5%
39.0%
Q2 25
29.8%
36.6%
Q1 25
33.5%
40.6%
Q4 24
1.2%
40.8%
Q3 24
-1.2%
39.2%
Operating Margin
CHE
CHE
LRN
LRN
Q3 26
20.5%
Q1 26
20.1%
Q4 25
15.7%
23.3%
Q3 25
12.0%
11.1%
Q2 25
11.0%
8.7%
Q1 25
14.6%
21.3%
Q4 24
27.7%
21.3%
Q3 24
23.5%
8.6%
Net Margin
CHE
CHE
LRN
LRN
Q3 26
14.1%
Q1 26
15.8%
Q4 25
12.0%
15.8%
Q3 25
10.3%
11.1%
Q2 25
8.5%
7.9%
Q1 25
11.1%
16.2%
Q4 24
22.0%
16.4%
Q3 24
19.4%
7.4%
EPS (diluted)
CHE
CHE
LRN
LRN
Q3 26
$1.93
Q1 26
Q4 25
$5.45
$2.12
Q3 25
$4.46
$1.40
Q2 25
$3.57
$0.96
Q1 25
$4.86
$2.02
Q4 24
$6.00
$2.03
Q3 24
$5.00
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHE
CHE
LRN
LRN
Cash + ST InvestmentsLiquidity on hand
$16.9M
$614.0M
Total DebtLower is stronger
$91.2M
$417.6M
Stockholders' EquityBook value
$848.0M
$1.6B
Total Assets
$1.5B
$2.4B
Debt / EquityLower = less leverage
0.11×
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHE
CHE
LRN
LRN
Q3 26
$614.0M
Q1 26
$16.9M
Q4 25
$74.5M
$625.7M
Q3 25
$129.8M
$715.1M
Q2 25
$249.9M
$985.3M
Q1 25
$173.9M
$723.7M
Q4 24
$178.3M
$717.5M
Q3 24
$238.5M
$522.2M
Total Debt
CHE
CHE
LRN
LRN
Q3 26
$417.6M
Q1 26
$91.2M
Q4 25
$417.2M
Q3 25
$416.8M
Q2 25
$416.3M
Q1 25
$415.9M
Q4 24
$415.5M
Q3 24
$415.1M
Stockholders' Equity
CHE
CHE
LRN
LRN
Q3 26
$1.6B
Q1 26
$848.0M
Q4 25
$979.4M
$1.5B
Q3 25
$1.1B
$1.5B
Q2 25
$1.2B
$1.5B
Q1 25
$1.2B
$1.4B
Q4 24
$1.1B
$1.3B
Q3 24
$1.2B
$1.2B
Total Assets
CHE
CHE
LRN
LRN
Q3 26
$2.4B
Q1 26
$1.5B
Q4 25
$1.5B
$2.3B
Q3 25
$1.6B
$2.3B
Q2 25
$1.7B
$2.3B
Q1 25
$1.7B
$2.2B
Q4 24
$1.7B
$2.1B
Q3 24
$1.8B
$2.0B
Debt / Equity
CHE
CHE
LRN
LRN
Q3 26
0.25×
Q1 26
0.11×
Q4 25
0.27×
Q3 25
0.27×
Q2 25
0.28×
Q1 25
0.29×
Q4 24
0.32×
Q3 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHE
CHE
LRN
LRN
Operating Cash FlowLast quarter
$88.2M
$117.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.33×
1.32×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHE
CHE
LRN
LRN
Q3 26
$117.0M
Q1 26
$88.2M
Q4 25
$133.5M
$91.8M
Q3 25
$83.4M
$-195.8M
Q2 25
$138.6M
$298.3M
Q1 25
$32.7M
$53.1M
Q4 24
$164.9M
$223.4M
Q3 24
$90.5M
$-142.0M
Free Cash Flow
CHE
CHE
LRN
LRN
Q3 26
Q1 26
Q4 25
$117.2M
$91.6M
Q3 25
$66.0M
$-196.1M
Q2 25
$122.8M
$297.9M
Q1 25
$19.5M
$52.9M
Q4 24
$152.2M
$222.9M
Q3 24
$77.0M
$-142.7M
FCF Margin
CHE
CHE
LRN
LRN
Q3 26
Q1 26
Q4 25
18.3%
14.5%
Q3 25
10.6%
-31.6%
Q2 25
19.8%
45.6%
Q1 25
3.0%
8.6%
Q4 24
37.0%
38.0%
Q3 24
19.7%
-25.9%
Capex Intensity
CHE
CHE
LRN
LRN
Q3 26
Q1 26
4.1%
Q4 25
2.6%
0.0%
Q3 25
2.8%
0.0%
Q2 25
2.6%
0.1%
Q1 25
2.1%
0.0%
Q4 24
3.1%
0.1%
Q3 24
3.5%
0.1%
Cash Conversion
CHE
CHE
LRN
LRN
Q3 26
1.32×
Q1 26
1.33×
Q4 25
1.74×
0.92×
Q3 25
1.30×
-2.85×
Q2 25
2.64×
5.81×
Q1 25
0.46×
0.53×
Q4 24
1.83×
2.32×
Q3 24
1.19×
-3.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHE
CHE

Homecare$371.1M88%
Inpatient$35.9M9%
Other$13.0M3%

LRN
LRN

General Education$357.5M57%
Middle - High School$259.5M41%
Adult$12.9M2%

Related Comparisons